STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 14,443,681 | $153,536,329 | 66.66% |
| M28 Capital Management LP | 346,190 | $3,680,000 | 4.86% |
| COWEN AND COMPANY, LLC | 3,721,659 | $39,561,235 | 3.28% |
| Redmile Group, LLC | 3,955,188 | $42,043,648 | 1.61% |
| RTW INVESTMENTS, LP | 4,390,558 | $46,671,632 | 0.89% |
| Birchview Capital, LP | 85,000 | $903,550 | 0.68% |
| Cormorant Asset Management, LP | 1,087,807 | $11,563,388 | 0.65% |
| Ikarian Capital, LLC | 215,200 | $2,287,576 | 0.36% |
| Octagon Capital Advisors LP | 185,669 | $1,973,661 | 0.28% |
| Granahan Investment Management | 532,880 | $5,664,514 | 0.17% |
| Simplify Asset Management Inc. | 122,796 | $1,305,321 | 0.17% |
| Baker Brothers Advisors | 2,130,238 | $22,644,430 | 0.13% |
| Ikarian Capital, LLC | 70,390 | $748,245 | 0.12% |
| Fort Point Capital Partners LLC | 75,429 | $801,810 | 0.11% |
| Artal Group S.A. | 250,000 | $2,658 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 56,626 | $602 | 0.06% |
| Virtus ETF Advisers LLC | 8,678 | $92,247 | 0.06% |
| PDT Partners, LLC | 23,592 | $250,783 | 0.03% |
| ALGERT GLOBAL LLC | 34,848 | $370 | 0.02% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 102,489 | $1,089,458 | 0.01% |
External links
This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.